Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.28693 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.25215 | 10 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.25721 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.21828 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.19916 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.29577 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.25889 | 10 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.23356 | 10 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.22912 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.23572 | 10 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.32657 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.23373 | 10 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.24553 | 10 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.24255 | 10 |